Published in Transplantation on October 01, 1992
The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation (1993) 0.95
Blood and alveolar lymphocyte subsets in pulmonary cytomegalovirus infection after lung transplantation. BMC Infect Dis (2001) 0.79
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med (1996) 10.49
The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med (1990) 4.25
Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med (1987) 3.58
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant (1993) 2.69
HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. J Immunol (1996) 2.58
Structure of the conserved GTPase domain of the signal recognition particle. Nature (1997) 2.52
Categories and particulars: prototype effects in estimating spatial location. Psychol Rev (1991) 2.36
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24
Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med (1996) 2.21
Thoracoscopic pancreatic denervation for pain control in irresectable pancreatic cancer. Br J Surg (1993) 2.17
A blood pressure clinic in a health centre. Postgrad Med J (1976) 2.12
Prediction of postoperative gas bloating after laparoscopic antireflux procedures based on 24-h pH acid reflux pattern. Surg Endosc (2002) 2.02
Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression. Oncogene (2006) 2.01
The multicenter AIDS Cohort Study, 1983 to …. Public Health (2011) 1.93
Thoracoscopy for empyema and hemothorax. Chest (1996) 1.90
Laparoscopic repair of large paraesophageal hernia is associated with a low incidence of recurrence and reoperation. Surg Endosc (2004) 1.89
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrob Agents Chemother (1996) 1.80
Prevalence of chronic pain after pulmonary resection by thoracotomy or video-assisted thoracic surgery. J Thorac Cardiovasc Surg (1994) 1.79
Snoring (I). Daytime sleepiness in regular heavy snorers. Chest (1991) 1.71
On the association between valproate and polycystic ovary syndrome. Epilepsia (2001) 1.65
Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. Antimicrob Agents Chemother (1995) 1.65
Preoperative severity of emphysema predictive of improvement after lung volume reduction surgery: use of CT morphometry. Chest (2000) 1.63
Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases. Eur J Cardiothorac Surg (2000) 1.62
Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen. J Infect Dis (2000) 1.61
Cost-utility of lung transplantation: a pilot study. J Heart Lung Transplant (1997) 1.60
Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1992) 1.57
Core to rind distribution of severe emphysema predicts outcome of lung volume reduction surgery. Am J Respir Crit Care Med (2001) 1.57
Laparoscopic repair of giant paraesophageal hernia: 100 consecutive cases. Ann Surg (2000) 1.55
Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg (1997) 1.55
Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J Virol (1989) 1.55
Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF). Hum Reprod (2010) 1.54
Effects of asthma on cell components in peripheral blood among smokers and non-smokers. Clin Exp Allergy (2003) 1.48
Anastomotic pitfalls in lung transplantation. J Thorac Cardiovasc Surg (1994) 1.47
Fluorescence bronchoscopic surveillance after curative surgical resection for non-small-cell lung cancer. Ann Surg Oncol (2000) 1.47
Functional changes in the structure of the SRP GTPase on binding GDP and Mg2+GDP. Nat Struct Biol (1999) 1.47
Single- versus double-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg (1998) 1.46
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. J Clin Invest (1997) 1.46
Endobronchial management of benign, malignant, and lung transplantation airway stenoses. Ann Thorac Surg (1995) 1.45
Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg (1999) 1.42
Nasotracheal jet ventilation for rigid endoscopy. Ann Thorac Surg (1994) 1.42
Predicting ICU length of stay following single lung transplantation. Chest (1996) 1.40
Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (1999) 1.40
Comparison of outcomes after single and bilateral lung transplantation for obstructive lung disease. J Heart Lung Transplant (1995) 1.40
Closure, covert warnings, and escalating child abuse. Child Abuse Negl (1995) 1.39
Epilepsy health consumer groups and charities; how representative of patients are they? The results of a pilot study. Seizure (2012) 1.38
The role of video-assisted thoracic surgery in thoracic oncological practice. Cancer Invest (1995) 1.38
Minimally invasive esophagectomy. Ann Thorac Surg (2000) 1.36
A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. Transplantation (1994) 1.30
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy. Cell Death Differ (2011) 1.30
Intrapulmonary concentrations of pyrazinamide. Antimicrob Agents Chemother (1999) 1.29
Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.29
Sudden unexpected death in epilepsy (SUDEP): don't ask, don't tell? J Neurol Neurosurg Psychiatry (2006) 1.26
Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology (1993) 1.24
Calnexin recognizes carbohydrate and protein determinants of class I major histocompatibility complex molecules. J Biol Chem (1995) 1.23
Detection of human immunodeficiency virus by reverse transcriptase assay, antigen capture assay, and radioimmunoassay. J Clin Microbiol (1987) 1.21
The action of progesterone and diethylstilboestrol on the dehydrogenase and esterase activities of a purified aldehyde dehydrogenase from rabbit liver. Biochem J (1977) 1.21
Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation (1999) 1.19
Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis (1996) 1.15
Structure of the phylogenetically most conserved domain of SRP RNA. RNA (1999) 1.14
Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assay. J Clin Microbiol (1995) 1.14
Fluorine-18-fluorodeoxyglucose uptake in pneumonia. J Nucl Med (1998) 1.10
Use of cryopreserved normal peripheral blood lymphocytes for isolation of human immunodeficiency virus from seropositive men. J Clin Microbiol (1988) 1.09
Effect of minimally invasive thoracic surgical approaches on acute and chronic postoperative pain. Chest Surg Clin N Am (1998) 1.08
Neighborhood environments, mobility, and health: towards a new generation of studies in environmental health research. Rev Epidemiol Sante Publique (2013) 1.08
Outcomes after minimally invasive esophagomyotomy. Ann Thorac Surg (2001) 1.07
Retracted High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ (2005) 1.06
Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation. J Thorac Cardiovasc Surg (1998) 1.06
Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest (1998) 1.05
Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med (1993) 1.03
Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. Transplantation (1996) 1.02
A semiquantitative microassay for measurement of relative number of blood mononuclear cells infected with human immunodeficiency virus. AIDS Res Hum Retroviruses (1990) 1.01
Effect of ischemic time on survival in clinical lung transplantation. Ann Thorac Surg (1999) 1.00
Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2. Hum Immunol (1994) 1.00
Selection of patients for lung volume reduction surgery using a power law analysis of the computed tomographic scan. Thorax (2003) 1.00
HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage. Cell Prolif (2009) 0.99
Extracutaneous angiosarcomas metastatic to the lungs: clinical and pathologic features of twenty-one cases. Mod Pathol (2001) 0.99
The role of thoracoscopy in lung cancer management. Chest (1998) 0.98
Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients. Ann Thorac Surg (1995) 0.98
Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties. Virology (1991) 0.98
Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design. J Biol Chem (1993) 0.98
Detection of human immunodeficiency virus type 1-specific memory cytotoxic T lymphocytes in freshly donated and frozen-thawed peripheral blood mononuclear cells. Clin Diagn Lab Immunol (1995) 0.97
HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage. Oncogene (2011) 0.97
Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy. Surg Endosc (2003) 0.97
Acute rejection of lung allografts with various immunosuppressive protocols. Ann Thorac Surg (1992) 0.96
Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids. Hum Reprod (1996) 0.96
A decade of lung transplantation. Ann Surg (1993) 0.96
Diagnosing the indeterminate pulmonary nodule: percutaneous biopsy versus thoracoscopy. Surgery (1995) 0.96
Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg (1997) 0.95
Endoscopic photodynamic therapy for obstructing esophageal cancer: 77 cases over a 2-year period. Surg Endosc (2000) 0.94
Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am J Respir Crit Care Med (1996) 0.93
Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine. Transplantation (1997) 0.93
Interactions of intestinal mediators in the mode of action of cholera toxin. J Med Microbiol (1994) 0.93
Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection. Clin Diagn Lab Immunol (1995) 0.93
Congenital urethral obstruction: Cobb's collar or prolapsed congenital obstructive posterior urethral membrane (COPUM). Br J Urol (1994) 0.93